Elevation Oncology (ELEV US)

Analysis

Health Care • United States

Elevation Oncology, Inc. operates as a biotechnology company. The Company focuses on the identification and targeted inhibition of tumor's specific drive alteration. Elevation Oncology serves patients in the United States.

Refresh

Focused

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00